Progesterone Market Size, Share & Trends Analysis Report, By Type (Synthetic, Natural), By Mode Of Delivery (Injectable, Suspended Form, Oral), By Application (Contraception, Endometrial Cancer, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Menopause, and Others) and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1004980 | Industries : Healthcare | Published On :January 2024 | Page Count : 211

Progesterone Market Size, Share & Trends Analysis Report, By Type (Synthetic, Natural), By Mode Of Delivery (Injectable, Suspended Form, Oral), By Application (Contraception, Endometrial Cancer, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Menopause, and Others) and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Progesterone market estimated at USD 1.2 billion in 2022 and which expected , at a compound annual growth rate (CAGR) of 13.17% from 2023 to 2030. Key players in the Progesterone market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Progesterone market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

PROGESTERONE MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Growing Demand in Women's Health:
The increasing demand for progesterone is driven by its vital role in women's health, particularly in hormonal therapies, fertility treatments, and pregnancy maintenance. Progesterone is essential for regulating the menstrual cycle, supporting pregnancy, and addressing hormonal imbalances. Rising awareness and advancements in women's healthcare contribute to the expanding market for progesterone-based products.

Regulatory Challenges and Stringent Approval Processes:

One of the key restraints in the progesterone market is the complex regulatory landscape and stringent approval processes for hormonal therapies. The need for comprehensive clinical trials and regulatory approvals poses challenges for market players in terms of time and resources. Stringent regulations aim to ensure safety and efficacy but can slow down the introduction of new progesterone-based products to the market.

How are Segments Performing in the Global Progesterone Market?

Progesterone Type Segment Breakdown
According to Analytical Market Research, the Progesterone market by type is segmented into Synthetic, Natural.
Progesterone Mode Of Delivery Segment Breakdown
According to Analytical Market Research, based on Mode Of Delivery, the market is segmented into Injectable, Suspended Form, Oral.
Progesterone Application Segment Breakdown
According to Analytical Market Research, based on Application Type the market is segmented into Contraception, Endometrial Cancer, Dysfunctional Uterine Bleeding, Hyperplastic Precursor Lesions, Menopause, and Others.

Progesterone Geographic Exploration

According to Analytical Market Research, the North America region is predicted to dominate the market, owing to the rise in the automotive industry in the region. Other regions competing in the market are North America, Europe, Middle East and Africa and Latin America respectively.

COMPETITIVE LANDSCAPE & RECENT DEVELOPMENT: Progesterone

The competitive landscape of the market is fragmented. The significant players rapidly evolve with new strategies to attain a competitive edge and capture significant market share.
• For Instance, in May 2023, The FDA has approved Veozah, a medicine designed to alleviate symptoms such as flushing and sweating in women with low estrogen levels.

Noticeable Players Functioning in The Global Progesterone Market Include:

• AbbVie, Inc
• Bayer AG
• Merck & Co., Inc.
• Pfizer, Inc
• Teva Pharmaceutical Industries Ltd
• Agile Therapeutics
• Amgen, Inc.
• Apothecus Pharmaceutical Corp
• Blairex Laboratories, Inc.
• Ferring B.V.

KEY BREAKDOWN: Progesterone Market

By Type:
• Synthetic
• Natural
By Application:
• Contraception
• Endometrial Cancer
• Dysfunctional Uterine Bleeding
• Hyperplastic Precursor Lesions
• Menopause
• Others
By Mode Of Delivery:
• Injectable
• Suspended Form
• Oral.
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o U.K.
o Russia
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o New Zealand
o Singapore
o Malaysia
o Rest of Asia
• Latin America
o Brazil
o Argentina
o Colombia
o Peru
o Chile
o Venezuela
o Rest of Latin America
• Middle East and Africa
o Saudi Arabia
o UAE
o Egypt
o Kuwait
o South Africa
o Rest of Middle East & Africa

1. Research Methodology
1.1. Global Progesterone Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data Sources
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Progesterone Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Applications
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Progesterone Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Progesterone Market Outlook: Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Type, 2023 – 2030
4.3.2.1. Synthetic
4.3.2.2. Natural
4.4. Global Progesterone Market Outlook: Application
4.4.1. Introduction / Key Findings
4.4.2. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
4.4.2.1. Cereals and Grains
4.4.2.2. Oilseeds
4.4.2.3. Pulses and legumes
4.4.2.4. Fruits and Vegetables
4.4.2.5. Others
4.5. Global Progesterone Market Outlook: Mode Of Delivery
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
4.5.2.1. Injectable
4.5.2.2. Suspended Form
4.5.2.3. Oral
5. Global Progesterone Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Progesterone Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Application
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
6.5.1. Synthetic
6.5.2. Natural
6.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
6.6.1. Cereals and Grains
6.6.2. Oilseeds
6.6.3. Pulses and legumes
6.6.4. Fruits and Vegetables
6.6.5. Others
6.7. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
6.7.1. Injectable
6.7.2. Suspended Form
6.7.3. Oral
7. Europe Progesterone Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Type
7.3.3. By Application
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
7.5.1. Synthetic
7.5.2. Natural
7.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
7.6.1. Contraception
7.6.2. Endometrial Cancer
7.6.3. Dysfunctional Uterine Bleeding
7.6.4. Hyperplastic Precursor Lesions
7.6.5. Menopause
7.6.6. Others
7.7. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
7.7.1. Injectable
7.7.2. Suspended Form
7.7.3. Oral
8. Asia Pacific Progesterone Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Type
8.3.3. By Application
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
8.5.1. Synthetic
8.5.2. Natural
8.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
8.6.1. Contraception
8.6.2. Endometrial Cancer
8.6.3. Dysfunctional Uterine Bleeding
8.6.4. Hyperplastic Precursor Lesions
8.6.5. Menopause
8.6.6. Others
8.7. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
8.7.1. Injectable
8.7.2. Suspended Form
8.7.3. Oral
9. Latin America Progesterone Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
9.5.1. Synthetic
9.5.2. Natural
9.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
9.6.1. Contraception
9.6.2. Endometrial Cancer
9.6.3. Dysfunctional Uterine Bleeding
9.6.4. Hyperplastic Precursor Lesions
9.6.5. Menopause
9.6.6. Others
9.7. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
9.7.1. Injectable
9.7.2. Suspended Form
9.7.3. Oral
10. Middle East & Africa Progesterone Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
10.5.1. Synthetic
10.5.2. Natural
10.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
10.6.1. Contraception
10.6.2. Endometrial Cancer
10.6.3. Dysfunctional Uterine Bleeding
10.6.4. Hyperplastic Precursor Lesions
10.6.5. Menopause
10.6.6. Others
10.7. Market Size (US$ Mn) and Forecast By Mode Of Delivery, 2023 – 2030
10.7.1. Injectable
10.7.2. Suspended Form
10.7.3. Oral
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. AbbVie, Inc
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Bayer AG.
11.3.3. Merck & Co., Inc.
11.3.4. Pfizer, Inc.
11.3.5. Teva Pharmaceutical Industries Ltd
11.3.6. Agile Therapeutics
11.3.7. Amgen, Inc.
11.3.8. Apothecus Pharmaceutical Corp
11.3.9. Blairex Laboratories, Inc.
11.3.10. Ferring B.V.